Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/3903508

N. Engl. J. Med. 1985 Dec 5 313 23 1485-92

Download in:

View as

Triples

General Info

PMID
3903508